Could have thrown a dart - many good plays today >>> CREG (5.95 - $6.60) Took SORL profits @ $6.22 - shorted XNET $13.00 & freaked when i saw it pop but still holding. ONCS in $2.50 - out @$2.80. IMDZ hit $5 in pre & shoulda took profits but thought it might go higher - WRONG & still holding. ROKU higher - AAOI started off good but... Watching HMNY & LEDS (old runner) up a bit today.
@Neil Allen forgot to say good morning Adding - just posted some info NVAX thread - have a big bag of that & may pick up some down here with insiders to start digging myself out - upcoming conf this week..
RTNB T12 halt lifted - back in.60's - on watch Just checked on VERI which is VERY sad >> $21's & so much for that pt but is on watch with PETZ that is back down to $16's. Also watching HAIR - made a nice move on Friday.
XRF: $9.50 - starting to move after terrific earnings last Fri: Third Quarter 2017 Financial Highlights Total gross billings on transaction and service fees[1] grew by 125% year-over-year to $43.1 million, or 76% over the previous quarter. Gross billings from consumption loans facilitated grew by 1258% year-over-year, representing more than a 12 times year-over-year increase, to $29.8 million, or 126% over the previous quarter. Gross billings from lifestyle loans facilitated were down 21% year-over-year to $13.4 million but up 18% sequentially over last quarter. Consumption loans facilitated account for 69% of total gross billings and are rising rapidly. Net revenue increased by 62% year-over-year to $27.2 million (after netting off customer acquisition incentives of $13.9 million) from $16.8 million (after netting off customer acquisition incentives of $1.5 million) in the prior year period, and 79% over the previous quarter from $15.2 million (after netting off customer acquisition incentives of $8.1 million) in the previous quarter.
BRKS: $26.60 - moving higher after Fri. earnings: Brooks Automation, Inc. (Nasdaq), a leading worldwide provider of automation and cryogenic solutions for multiple markets, including semiconductor manufacturing and life sciences, today reported financial results for the fourth quarter of the fiscal year ended September 30, 2017. Fiscal Fourth Quarter of 2017 Financial and Operational Highlights: Total revenue was $182 million; 15% growth compared to 2016 Q4; Life Sciences revenue was $44 million; 39% growth vs. 2016 Q4; Semiconductor revenue was $138 million; 10% growth vs. 2016 Q4; GAAP Net Income was $17 million with diluted EPS of $0.25; Non-GAAP Net Income was $25 million with diluted EPS of $0.35; and Cash flow from operations was $35 million. Fiscal Year 2017 Financial and Operational Highlights: Total revenue was $693 million; 24% growth compared to 2016, with 22% organic growth; Life Sciences revenue was $149 million; 38% growth, with 27% organic growth; Semiconductor revenue was $544 million; 20% growth, with all being organic growth; GAAP Net Income was $63 million with diluted EPS of $0.89; Non-GAAP Net Income was $87 million with diluted EPS of $1.23; and Cash flow from operations was $96 million.
don't wanna hold with er coming up so just covered @ $12.18 & will try to remember to pick it back up this time
ONCS trying for $3 again well it was but needs to breath & have been sitting on my fingers b/c wanted to get back in but not up here & looks like i am getting a nice pull back now
$500. Growth >> LOSS Test started - definitely should not be messing with stocks under $1!!!!!!!!!!!!!! Picked up 100 shares RTNB @ .70 & just saw 8k delisting news & probably should sell but gonna wait to see if i can at least break even & if not then will sell for loss @.60 & have 1 cent to go. Ok my $500 account just went down so no more stocks under $1. i sell & of course it moves back up - will be really mad if this thing hits $1+
WRONG - down to $92 now & unreal how these companies mess with stocks that are moving good >> Sage Therapeutics Announces Proposed Public Offering of Common Stock - https://finance.yahoo.com/news/sage-therapeutics-announces-proposed-public-210100841.html edit - looking @ wrong stock SAGE not back up to $97
Not sure how i missed this but ONCE rapid pull back/CRASH was due to 8K about warrants. https://www.sec.gov/Archives/edgar/data/1444307/000149315217012880/form8-k.htm
partial watch >> CALA (data not that great so we get some good shopping prices coming up ) - XNET - ROKU - PETZ
eesh....CALA lost 28.72% to close Monday's trading at $11.72. News: The Company reported data from its phase 1/2 study of CB-839, combined with Opdivo in patients with advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer. The overall response rate was 19% and overall disease control rate was 44% in melanoma patients. The melanoma patients were progressing on a checkpoint inhibitor at study entry. The overall response rate was 21% in renal cell carcinoma IO naïve cohort with disease control rate of 74%. Large gap to fill. XNET - going to the low 7's imo - 50 DMA: $6.17
@Neil Allen saw CALA results yesterday & wasn't sure how much it would fall but might be heading to around10.50 (or under) AND hope it recovers b/c has been a pretty good swing that i don't wanna add to my lost list Didn't post this in my list above but RARE is another one on radar - PDUFA priority review due 11/16 - has been coming up nice from bottom. AND no doubt XNET will be hitting my $7's target - came close last time & lost track of it with other plays BUT have it right under my nose this time & don't think er is gonna support this increase @ all
Dayum. BWLD up pre market $148 from $117 close. Roark capitol wanting to buy it at $150. Thats been one of my long time rotations and solid growth plays. Wish i had contracts on that one ATM. That seriously could be quit your dayjob kind of money.
